A Patient with Stage IV Gastric Cancer who Survived more than Five Years after Gastrectomy
Takaoka, A.; Usui, S.; Kumaki, Y.; Akutsu, T.; Matsunaga, H.; Tashiro, M.; Arita, K.; Haruki, S.; Ito, K.; Matsumoto, A.; Takiguchi, N.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2371-2373
2016
ISSN/ISBN: 0385-0684 PMID: 28133325 Document Number: 689575
The prognosis of patients with Stage IV gastric cancer is generally poor. The 5-year overall survival rate is less than 10%. The patient was a 73-year-old man with Stage IV gastric cancer. Before chemotherapy, peritoneal dissemination was observed using staging laparoscopy. The patient received first-line chemotherapy with TS-1 plus CDDP. Renal function worsened and consequently the therapy was stopped. He received 3 courses of chemotherapy with weekly PTX. The peritoneal dissemination had disappeared by the second staging laparoscopy and he underwent distal gastrectomy. The final diagnosis was pT4a, ly2, v1, pN2(4/16),M0, fStage III B. The patient received adjuvant chemotherapy of TS-1 for 4 years and 8months after gastrectomy. More than 5 year after gastrectomy, the patient is alive without recurrence.